Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group.

BACKGROUND--High dose inhaled glucocorticosteroids are increasingly used in the management of patients with moderate to severe asthma. Although effective, they may cause systemic side effects. Fluticasone propionate is a topically active inhaled glucocorticosteroid which has few systemic effects at...

詳細記述

書誌詳細

出版年:	Thorax
主要な著者:	Fabbri, L., Burge, P. S., Croonenborgh, L., Warlies, F., Weeke, B., Ciaccia, A., Parker, C.
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMJ Publishing Group 1993
主題:	Research Article
オンライン･アクセス:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC464708/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8211872/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/thx.48.8.817
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!